FDA Investigator: Christina A. Capacci-Daniel

- Christina A. Capacci-Daniel first started conducting FDA inspections in 2014, with the last inspection in 2018. Over that time, Christina A. Capacci-Daniel has conducted 10 inspections at 9 companies across 10 sites.

Documents

FDA 483 Alnylam Pharmaceuticals, Cambridge | May 2018

Available - $199
Christina A. Capacci-Daniel
Human Drug Form 483

FDA 483 Vertex Pharmaceuticals, Inc., Boston | 2017

Out-of-stock
Christina A. Capacci-Daniel
Human Drug Form 483

FDA 483 Baxter Oncology GmbH, Halle (Westf.) | 2017

Out-of-stock
Christina A. Capacci-Daniel
Human Drug Form 483

FDA 483 Janssen Ortho, Llc, Gurabo | 2016

Out-of-stock
Christina A. Capacci-Daniel
Human Drug Form 483

FDA 483 ASM Aerosol Service AG, Mohlin | 2015

Out-of-stock
Christina A. Capacci-Daniel
Human Drug Form 483

FDA 483 Wyeth BioPharma Division of Wyeth Pharmaceuticals, Inc., Andover | 2014

Out-of-stock
Christina A. Capacci-Daniel
Human Drug Form 483

FDA 483 Impax Laboratories (Taiwan) Inc., Jhunan, Miao-Li County | 2014

Out-of-stock
Christina A. Capacci-Daniel
Human Drug Form 483

FDA 483 Impax Laboratories (Taiwan) Inc., Jhunan, Miao-Li County | 2014

Out-of-stock
Christina A. Capacci-Daniel
Human Drug Form 483